Log in
Enquire now
‌

US Patent 10807994 Heterocyclic compounds and uses thereof

Patent 10807994 was granted and assigned to Nuvation Bio on October, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Nuvation Bio
Nuvation Bio
Current Assignee
Nuvation Bio
Nuvation Bio
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10807994
Date of Patent
October 20, 2020
Patent Application Number
16155841
Date Filed
October 9, 2018
Patent Citations Received
‌
US Patent 11999728 Estrogen receptor modulators
0
‌
US Patent 11332473 Substituted pyrazolo[3,4-d]pyrimidines as Wee1 inhibitors
‌
US Patent 11339162 Estrogen receptor modulators
Patent Primary Examiner
‌
Brian E McDowell
No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10807994 Heterocyclic compounds and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.